Literature DB >> 2826704

Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes with recurrent abdominal symptoms and coenzyme Q10 administration.

M Yamamoto1, T Sato, M Anno, H Ujike, M Takemoto.   

Abstract

A male with mitochondrial myopathy, encephalopathy, lactic acidemia, and strokelike episodes is reported. He had also recurrent episodes of ileus. Muscle biopsy revealed ragged-red fibres. The cytochemistry of cytochrome c oxidase (CCO) showed scattered nonstained fibres, while all muscle fibres were heavily stained by immunocytochemistry using CCO antibody. These findings suggest that partical CCO deficiency may be present in the skeletal muscles of the patient. NADH cytochrome c reductase in the patient's muscle mitochondria was low compared with normal controls (about 26%), although succinate cytochrome c reductase was normal. Coenzyme Q10 administration (90 mg/day) did not improve CSF lactate levels, but did decrease plasma lactate levels. His muscle weakness slightly improved.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2826704      PMCID: PMC1032560          DOI: 10.1136/jnnp.50.11.1475

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  14 in total

1.  Mitochondrial encephalomyopathies: a group of neuromuscular disorders with defects in oxidative metabolism.

Authors:  Y Shapira; S Harel; A Russell
Journal:  Isr J Med Sci       Date:  1977-02

2.  Familial poliodystrophy, mitochondrial myopathy, and lactate acidemia.

Authors:  Z H Hart; C H Chang; E V Perrin; J S Neerunjun; R Ayyar
Journal:  Arch Neurol       Date:  1977-03

3.  A partial deficiency of cytochrome c oxidase in chronic progressive external ophthalmoplegia.

Authors:  M A Johnson; D M Turnbull; D J Dick; H S Sherratt
Journal:  J Neurol Sci       Date:  1983-07       Impact factor: 3.181

4.  Kearns-Sayre syndrome with reduced plasma and cerebrospinal fluid folate.

Authors:  R J Allen; S DiMauro; D L Coulter; A Papadimitriou; S P Rothenberg
Journal:  Ann Neurol       Date:  1983-06       Impact factor: 10.422

5.  Ultrastructural study of the childhood mitochondrial myopathic syndrome associated with lactic acidosis.

Authors:  Y Kobayashi; S Miyabayashi; G Takada; K Narisawa; K Tada; T Y Yamamoto
Journal:  Eur J Pediatr       Date:  1982-09       Impact factor: 3.183

6.  A mitochondrial myopathy characterized by a deficiency in reducible cytochrome b.

Authors:  J A Morgan-Hughes; P Darveniza; S N Kahn; D N Landon; R M Sherratt; J M Land; J B Clark
Journal:  Brain       Date:  1977-12       Impact factor: 13.501

7.  Fatal lipid storage myopathy with deficiency of cytochrome-c-oxidase and carnitine. A contribution to the combined cytochemical-finestructural identification of cytochrome-c-oxidase in longterm frozen muscle.

Authors:  J Müller-Höcker; D Pongratz; T Deufel; J M Trijbels; W Endres; G Hübner
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1983

8.  Mitochondrial myopathy and encephalopathy: three cases--a deficiency of NADH-CoQ dehydrogenase?

Authors:  P L Holliday; A R Climie; J Gilroy; M Z Mahmud
Journal:  Neurology       Date:  1983-12       Impact factor: 9.910

9.  Mitochondrial encephalomyopathy: fluctuating symptoms and CT.

Authors:  T Yamamoto; H Beppu; T Tsubaki
Journal:  Neurology       Date:  1984-11       Impact factor: 9.910

10.  Nondroplet ultrastructural demonstration of cytochrome oxidase activity with a polymerizing osmiophilic reagent, diaminobenzidine (DAB).

Authors:  A M Seligman; M J Karnovsky; H L Wasserkrug; J S Hanker
Journal:  J Cell Biol       Date:  1968-07       Impact factor: 10.539

View more
  7 in total

1.  Isolated and combined deficiencies of NADH dehydrogenase (complex I) in muscle tissue of children with mitochondrial myopathies.

Authors:  G C Korenke; H A Bentlage; W Ruitenbeek; R C Sengers; W Sperl; J M Trijbels; F J Gabreels; F A Wijburg; V Wiedermann; F Hanefeld
Journal:  Eur J Pediatr       Date:  1990-12       Impact factor: 3.183

2.  Spontaneous Kearns-Sayre/chronic external ophthalmoplegia plus syndrome associated with a mitochondrial DNA deletion: a slip-replication model and metabolic therapy.

Authors:  J M Shoffner; M T Lott; A S Voljavec; S A Soueidan; D A Costigan; D C Wallace
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

3.  Myopathy in long-term AZT therapy: clinical, electrophysiological and biopsy study in 67 HIV+ subjects.

Authors:  M Spadaro; G Tilia; M C Massara; A Damiani; L Parisi; G Tomelleri; G D'Offizi; C Morocutti
Journal:  Ital J Neurol Sci       Date:  1993-06

4.  Stroke-like episodes in familial mitochondrial encephalomyopathy: clinical and biochemical aspects.

Authors:  M S Damian; H Reichmann; H J Schütz; W Dorndorf; W Schachenmayr
Journal:  J Neurol       Date:  1991-04       Impact factor: 4.849

Review 5.  Coenzyme Q10 depletion in medical and neuropsychiatric disorders: potential repercussions and therapeutic implications.

Authors:  Gerwyn Morris; George Anderson; Michael Berk; Michael Maes
Journal:  Mol Neurobiol       Date:  2013-06-13       Impact factor: 5.590

6.  Causes of low muscle coenzyme-Q levels beyond primary coenzyme-Q-deficiency.

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  Mol Genet Metab Rep       Date:  2018-04-05

7.  Urogenital symptoms in mitochondrial disease: overlooked and undertreated.

Authors:  O V Poole; T Uchiyama; I Skorupinska; M Skorupinska; L Germain; D Kozyra; S Holmes; N James; E Bugiardini; C Woodward; R Quinlivan; A Emmanuel; M G Hanna; J N Panicker; R D S Pitceathly
Journal:  Eur J Neurol       Date:  2019-04-30       Impact factor: 6.089

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.